| Date Filed | Type | Description |
| 04/28/2021 |
GN
| InMed Pharmaceuticals Submits Clinical Trial Applications to Evaluate INM-755 (Cannabinol) Cream in a Phase 2 Trial for Epidermolysis Bullosa |
| 04/27/2021 |
GN
| InMed Pharmaceuticals Announces Voluntary Delisting from TSX |
| 04/26/2021 |
GN
| InMed Pharmaceuticals Achieves 2g/L Cannabinoid Yield with IntegraSyn™ |
| 03/03/2021 |
GN
| InMed to Present at Virtual Conferences in March 2021 |
| 06/12/2018 |
GN
| InMed Pharmaceuticals announces increase in Bought Deal offering to $13 million |
| 06/12/2018 |
GN
| InMed Pharmaceuticals Announces $10 Million Bought Deal |
| 02/10/2014 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 10/10/2013 |
SC 13G/A
| WELLS FARGO & COMPANY reports a |
| 09/18/2013 |
SC 13D/A
| GAMCO INVESTORS, INC. ET AL reports a 0% stake in Intermec, Inc. |
| 09/17/2013 |
8-K
| Resignation/termination of a director |
| 09/13/2013 |
8-K
| Other Events, Financial Statements and Exhibits |
| 09/11/2013 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/08/2013 |
8-K
| Quarterly results |
| 08/08/2013 |
10-Q
| Quarterly Report for the period ended June 30, 2013 |
| 08/08/2013 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 06/24/2013 |
8-K
| Other Events |
| 06/10/2013 |
8-K
| Other Events |
| 05/03/2013 |
10-Q
| Quarterly Report for the period ended March 31, 2013 |
| 04/29/2013 |
10-K/A
| Annual Report for the period ended December 31, 2012 [amend] |
| 03/29/2013 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 03/19/2013 |
8-K
| Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits |
| 03/15/2013 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 03/15/2013 |
8-K
| Other Events |
| 03/12/2013 |
8-K
| Other Events, Financial Statements and Exhibits |
| 03/12/2013 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 03/11/2013 |
8-K
| Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits |
| 03/11/2013 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 03/11/2013 |
10-K
| Annual Report for the period ended December 31, 2012 |
| 03/11/2013 |
SC 13G
| Intermec, Inc. reports a 11.5% stake in Intermec, Inc |
| 03/06/2013 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 02/15/2013 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| 02/14/2013 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition |
| 02/11/2013 |
SC 13G/A
| Intermec, Inc. reports a 3.8% stake in INTERMEC INC |
| 02/11/2013 |
SC 13G/A
| Intermec, Inc. reports a 12.8% stake in INTERMEC INC |
|